Hartmann Capital invests in early-stage frontier technology companies that are redefining human capability and commerce through advancements in Generative AI, Brain-Computer Interfaces, XR & Spatial Computing, Programmable Biology, and Robotics.
About Hartmann Capital
Hartmann Capital is an investment firm with a hartmanncapital.com website and LinkedIn and Twitter presence, with a thesis that has historically included crypto, digital assets, and frontier technology investing rather than traditional healthcare or AI sector focus. The public footprint does not surface explicit healthcare AI investing positioning. For healthcare AI founders, Hartmann is most relevant only if your business sits at the explicit intersection of healthcare and crypto, digital assets, or frontier financial infrastructure: decentralized health data platforms, blockchain-based clinical trial infrastructure, or healthcare token economies. Pure clinical AI, digital health, or healthcare workflow software is unlikely to be in scope. Plausible check sizes for vehicles of this profile run 100K to 1M, often with a crypto or digital asset thesis lens. Founders building traditional healthcare AI without a crypto angle should look elsewhere; do not bend a healthcare AI pitch to fit a crypto narrative, the partners will see through it and the value-add will be muted. Entry path is LinkedIn outreach to fund leadership with a sharp crypto-and-healthcare framing if applicable, or through digital asset operator networks. The firm reads inbound from crypto-aligned founders. Diligence will focus on digital asset thesis fit, technical architecture, and tokenomics or decentralization angles where relevant. Realistic founder triage for healthcare AI: this fund is unlikely to be the right partner unless your business has a clear digital asset wedge. Reallocate fundraising hours to healthcare-thesis-aligned investors. The honest read is that pursuing a fund whose published thesis is fundamentally orthogonal to your business is poor use of scarce founder time, regardless of how much capital they have.
Founder reviews
Healthcare AI tools backed by Hartmann Capital
Tools made by companies in Hartmann Capital's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Hartmann Capital's portfolio not currently in our directory.
- iOrganBio
- Paradromics
- Orchid
- Neurable
- Foundational Bio
- Neuma
- Respeecher
- DressX
- Sloyd
- Zibra AI
- TRIPP
Team
Pitch / review this investor
Have you raised from Hartmann Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).